Abstract
Type I interferon (IFN) signaling is mediated through several signaling pathways, including the Janus kinase and signal transducer and activator (JAK-STAT) and p38 mitogen-activated protein (MAP) kinase pathways. The VP24 protein of Ebolavirus is an IFN antagonist, blocking type I IFN signaling through the JAK-STAT pathway. Here, we show that, in 293 cells, VP24 also interferes with the p38 MAP kinase pathway by blocking IFN-β-stimulated phosphorylation of p38-α. Similar inhibition was not observed in HeLa cells, suggesting cell type-specific differences in signal transduction.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Activating Transcription Factor 4 / genetics
-
Activating Transcription Factor 4 / metabolism
-
Anthracenes / pharmacology
-
Ebolavirus / metabolism*
-
Enzyme Inhibitors / pharmacology
-
HEK293 Cells
-
Humans
-
Imidazoles / pharmacology
-
Interferon-beta / genetics
-
Interferon-beta / metabolism
-
JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
JNK Mitogen-Activated Protein Kinases / metabolism
-
Phosphorylation
-
Pyridines / pharmacology
-
Signal Transduction
-
Viral Proteins / genetics
-
Viral Proteins / metabolism*
-
p38 Mitogen-Activated Protein Kinases / genetics
-
p38 Mitogen-Activated Protein Kinases / metabolism*
Substances
-
ATF4 protein, human
-
Anthracenes
-
Enzyme Inhibitors
-
Imidazoles
-
Pyridines
-
VP24 protein, Ebola virus
-
Viral Proteins
-
Activating Transcription Factor 4
-
pyrazolanthrone
-
Interferon-beta
-
JNK Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
SB 203580